Annexon, Inc. Share Price
ANNXAnnexon, Inc. Stock Performance
Open $5.80 | Prev. Close $5.75 | Circuit Range N/A |
Day Range $5.58 - $5.85 | Year Range $1.29 - $7.16 | Volume 92,403 |
Average Traded $5.72 |
Annexon, Inc. Share Price Chart
About Annexon, Inc.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Annexon, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $5.80 | $5.71 | +1.69% |
05-Feb-26 | $5.96 | $5.62 | -6.80% |
04-Feb-26 | $6.46 | $6.03 | -7.02% |
03-Feb-26 | $6.42 | $6.48 | +1.57% |
02-Feb-26 | $6.18 | $6.38 | +2.33% |
30-Jan-26 | $6.64 | $6.24 | -4.37% |
29-Jan-26 | $6.32 | $6.52 | +3.74% |
FAQs on Annexon, Inc. Share Price
Can I buy Annexon, Inc. shares in India?
What is the share price of Annexon, Inc.?
What is the 5 year returns of Annexon, Inc.?
What are the high & low stock price of Annexon, Inc. today?
What is the 52-week high and low of Annexon, Inc. stock?